Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 61
  • 0 comments

FDA approve RANOLAZINE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 58
  • 0 comments

FDA approve CARBIDOPA; ENTACAPONE; LEVODOPA

Comment Full text

RECORDATI RARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 60
  • 0 comments

FDA approve OSILODROSTAT PHOSPHATE

Comment Full text

MSN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 50
  • 0 comments

FDA approve RUFINAMIDE

Comment Full text

ADVAGEN PHARMA LTD

  • FDA Approval
  • April 16, 2025, 13:06 UTC
  • 70
  • 0 comments

FDA approve METOPROLOL

Comment Full text

BIOCON BIOLOGICS INC

  • FDA Approval
  • April 16, 2025, 12:53 UTC
  • 64
  • 0 comments

FDA approve BEVACIZUMAB-NWGD

Comment Full text

ENCUBE

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 58
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 58
  • 0 comments

FDA approve FLUOCINOLONE ACETONIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 60
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

DR REDDYS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 59
  • 0 comments

FDA approve TRIENTINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 199
  • 200
  • 201
  • 202
  • 203
  • Next

Search

News categories

  • Technical Exchange News(11369)
  • Event(2790)
  • SEC News(205817)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(134632)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin